ACCESSION: MSBNK-SMB_Measured-HSA015P0114013
RECORD_TITLE: Characterized; Epsilon-caprolactam; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 44
COMMENT: RAW_SPEC {'EL19_pos_2685': {'bp': 1883919.0, 'sum': 3797625.0}, 'EL01_pos_2649': {'bp': 1464964.0, 'sum': 3003949.0}, 'EL16_pos_2757': {'bp': 1579053.0, 'sum': 3303856.0}, 'EL06_pos_2661': {'bp': 1724362.0, 'sum': 3651031.0}, 'EL11_pos_1755': {'bp': 1290983.0, 'sum': 2919006.0}, 'EL09_pos_3567': {'bp': 1434933.0, 'sum': 2952369.0}, 'EL16_pos_2637': {'bp': 1560555.0, 'sum': 3279320.0}, 'EL05_pos_2655': {'bp': 1802622.0, 'sum': 3732102.0}, 'EL17_pos_2649': {'bp': 1740783.0, 'sum': 3644088.0}, 'EL14_pos_3585': {'bp': 1524432.0, 'sum': 2978609.0}, 'EL05_pos_1755': {'bp': 1570845.0, 'sum': 3481531.0}, 'EL09_pos_1767': {'bp': 1573974.0, 'sum': 3488319.0}, 'EL24_pos_1767': {'bp': 1329619.0, 'sum': 2961157.0}, 'EL02_pos_3585': {'bp': 1547787.0, 'sum': 3050040.0}, 'EL01_pos_3567': {'bp': 1392746.0, 'sum': 2677273.0}, 'EL12_pos_1755': {'bp': 1474860.0, 'sum': 3224842.0}, 'EL05_pos_3579': {'bp': 1629497.0, 'sum': 3263758.0}, 'EL04_pos_3561': {'bp': 1425397.0, 'sum': 2813192.0}, 'EL07_pos_3561': {'bp': 1442097.0, 'sum': 2893748.0}, 'EL23_pos_1749': {'bp': 1324495.0, 'sum': 3034316.0}, 'EL14_pos_1761': {'bp': 1437607.0, 'sum': 3180159.0}, 'EL06_pos_3573': {'bp': 1643178.0, 'sum': 3234753.0}, 'EL20_pos_1743': {'bp': 1363082.0, 'sum': 2988248.0}, 'EL06_pos_1767': {'bp': 1588270.0, 'sum': 3621566.0}, 'EL10_pos_1749': {'bp': 1462819.0, 'sum': 3096366.0}, 'EL02_pos_1761': {'bp': 1630852.0, 'sum': 3599640.0}, 'EL04_pos_1749': {'bp': 1330398.0, 'sum': 2976489.0}, 'EL22_pos_2673': {'bp': 1744003.0, 'sum': 3674231.0}, 'EL02_pos_2661': {'bp': 1735809.0, 'sum': 3735481.0}, 'EL20_pos_2649': {'bp': 1564254.0, 'sum': 3239179.0}, 'EL19_pos_2997': {'bp': 1834704.0, 'sum': 4169250.0}, 'EL21_pos_2643': {'bp': 1674233.0, 'sum': 3555751.0}, 'EL10_pos_3573': {'bp': 1398426.0, 'sum': 2758313.0}, 'EL12_pos_3573': {'bp': 1658896.0, 'sum': 3237574.0}, 'EL08_pos_3567': {'bp': 1441950.0, 'sum': 2832745.0}, 'EL08_pos_2661': {'bp': 1644973.0, 'sum': 3284082.0}, 'EL11_pos_3561': {'bp': 1392875.0, 'sum': 2846249.0}, 'EL10_pos_2655': {'bp': 1578729.0, 'sum': 3240553.0}, 'EL24_pos_2673': {'bp': 1514074.0, 'sum': 3105154.0}, 'EL18_pos_2655': {'bp': 1494338.0, 'sum': 3138462.0}, 'EL04_pos_2679': {'bp': 1530253.0, 'sum': 3213139.0}, 'EL13_pos_2661': {'bp': 1575301.0, 'sum': 3248931.0}, 'EL13_pos_3585': {'bp': 1399009.0, 'sum': 2794944.0}, 'EL14_pos_2667': {'bp': 1507252.0, 'sum': 3172452.0}}
COMMENT: RETENTION_TIME_STDEV 1.129
COMMENT: PRECURSOR_M/Z_RAW 114.091713
COMMENT: PRECURSOR_M/Z_STDEV 0.000049
COMMENT: PRECURSOR_IN_MS1 mz 114.091296; int 281.157; delta(ppm) 0.650897
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.363; C6H11NO; [M+H]+; delta(ppm) -0.362562
COMMENT: PROPOSED_MF MS-FINDER 3.207; C6H11NO; [M+H]+; delta(ppm) -0.362974
COMMENT: PROPOSED_MF SIRIUS5_Sirius 54.764; C6H11NO; [M+H]+; delta(ppm) -0.362974
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11NO; [M+H]+; delta(ppm) -0.362974
COMMENT: PROPOSED_MF SIRIUS6_Sirius 73.322; C6H11NO; [M+H]+; delta(ppm) -0.362974
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.985; C4H9N4; [M+H]+; delta(ppm) 11.405482
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11NO; [M+H]+; delta(ppm) -0.362974
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.981; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; ON=C1CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.938; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; C(CCC#N)CCO
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.783; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; C\C=C(/C)CC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.769; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; O=C(C(=CN)C)CC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.758; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; CC(=O)C1CCCN1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.409; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; Epsilon-caprolactam
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.342; WYFGJRVCBCRNRV-UHFFFAOYSA-N; [M+H]+; 2-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.342; HZRZMHNRCSIQFT-UHFFFAOYSA-N; [M+H]+; 2,4,4-trimethyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.327; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2-dimethyl-3H-pyrrole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.290; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; 1-Piperidinecarboxaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.238; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.221; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; UNPD24125
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.221; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.134; CEYVKTKJMLCDGD-UHFFFAOYSA-N; [M+H]+; 1-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.120; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; UNPD133545
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.113; YICILWNDMQTUIY-UHFFFAOYSA-N; [M+H]+; 2-methylidenepentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.082; YFSGRMONVCFYTC-UHFFFAOYNA-N; [M+H]+; 2,5-Dihydro-2,4,5-trimethyloxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.068; DVQLGAFYVKJEDE-UHFFFAOYSA-N; [M+H]+; N,N-dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.030; GXCJLVVUIVSLOQ-UHFFFAOYSA-N; [M+H]+; 2-propyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.030; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.020; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.992; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.986; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.984; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.960; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.955; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; cyclohexanone oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.947; RHDNNKQDLVQQLJ-UHFFFAOYNA-N; [M+H]+; 1-isopropylaziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.943; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; UNPD121086
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.916; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; (2R)-2-ethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.891; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; 6-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.863; XEXRMKMMZOZZIF-UHFFFAOYSA-N; [M+H]+; (1-methoxybut-1-en-2-yl)(methylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FDCJCIRHYZNLDV-HWKANZROSA-N; [M+H]+; UNPD24125
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; YICILWNDMQTUIY-UHFFFAOYSA-N; [M+H]+; 2-methylidenepentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.760; WXYJAPNVTUNRQN-UHFFFAOYSA-N; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.682; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; cyclohexanone oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.673; CPOBJDVABFKLDU-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2-dimethyl-3H-pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.651; ZRBMHTFPJMSUDJ-MLHKIVSYNA-N; [M+H]+; UNPD133545
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.628; SEMLMBCSWHCHHS-RXMQYKEDSA-N; [M+H]+; (2R)-2-ethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.628; FYCFJMPASVKULQ-UHFFFAOYNA-N; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.609; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; Epsilon-caprolactam
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.557; OKBBHAGZRNKJPR-UHFFFAOYSA-N; [M+H]+; 6-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.520; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.512; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.510; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; 1-Piperidinecarboxaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.491; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; UNPD121086
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.468; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.436; DVQLGAFYVKJEDE-UHFFFAOYSA-N; [M+H]+; N,N-dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.414; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.385; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.370; GXCJLVVUIVSLOQ-UHFFFAOYSA-N; [M+H]+; 2-propyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.343; HZRZMHNRCSIQFT-UHFFFAOYSA-N; [M+H]+; 2,4,4-trimethyl-4,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.332; YFSGRMONVCFYTC-UHFFFAOYNA-N; [M+H]+; 2,5-Dihydro-2,4,5-trimethyloxazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.246; RHDNNKQDLVQQLJ-UHFFFAOYNA-N; [M+H]+; 1-isopropylaziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.182; XEXRMKMMZOZZIF-UHFFFAOYSA-N; [M+H]+; (1-methoxybut-1-en-2-yl)(methylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.090; WYFGJRVCBCRNRV-UHFFFAOYSA-N; [M+H]+; 2-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.073; CEYVKTKJMLCDGD-UHFFFAOYSA-N; [M+H]+; 1-isocyano-1-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.073; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.760; JBKVHLHDHHXQEQ-UHFFFAOYSA-N; [M+H]+; azepan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.042; QNILTEGFHQSKFF-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.723; LJJFNFYPZOHRHM-UHFFFAOYSA-N; [M+H]+; 1-isocyano-2-methoxy-2-methylpropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.518; VEZUQRBDRNJBJY-UHFFFAOYSA-N; [M+H]+; N-cyclohexylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.315; FEWLNYSYJNLUOO-UHFFFAOYSA-N; [M+H]+; piperidine-1-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.271; ZFPGARUNNKGOBB-UHFFFAOYSA-N; [M+H]+; 1-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; XRLDSWLMHUQECH-UHFFFAOYSA-N; [M+H]+; cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; NWIIFKYGKOLKML-UHFFFAOYSA-N; [M+H]+; (1-aminocyclopent-3-en-1-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; JUUPISMKQGJUEL-UHFFFAOYSA-N; [M+H]+; 1-aminohex-5-yn-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.105; AAQLNWLDUWCQOD-LURJTMIESA-N; [M+H]+; (2S)-2-aminohex-5-yn-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.064; UXKZFJDNFBNQHE-RITPCOANSA-N; [M+H]+; [(1S,4R)-4-aminocyclopent-2-en-1-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.059; VCUVETGKTILCLC-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-1-oxido-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; YBZQRYWKYBZZNT-BYPYZUCNSA-N; [M+H]+; (1R)-2,2-dimethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; BWKHTRYJANAUCO-UHFFFAOYSA-N; [M+H]+; 2-aminospiro[2.3]hexan-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.043; VOABPFRENHXUQX-UHFFFAOYSA-N; [M+H]+; 3-cyclopropylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.030; BHIQRZLQBMERJY-UHFFFAOYSA-N; [M+H]+; 5-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.024; LMDVLNHRTIBTGT-UHFFFAOYSA-N; [M+H]+; 4-azaspiro[2.4]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.022; BOTJOIYABJNMEW-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.1]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.019; SFEYJTLKTWQWMB-HSUXUTPPSA-N; [M+H]+; [(1R,2S,5S)-3-azabicyclo[3.1.0]hexan-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; UHSSZVLSEAEFTI-UHFFFAOYSA-N; [M+H]+; (3-amino-1-bicyclo[1.1.1]pentanyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; WYQKKRBHVXDDTB-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)bicyclo[1.1.1]pentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.010; VQIILGJJJQKLPC-PBXRRBTRSA-N; [M+H]+; (1R,5R,6S)-2-azabicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.009; XFBQQBXIYXFYKY-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.2.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; SEHVUORORNIEOB-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.0]hexan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; NZCBOEIGQAQLCD-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[4.1.0]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.006; YXNPVBNVXFDPHF-NTSWFWBYSA-N; [M+H]+; (1S,6S)-3-azabicyclo[4.1.0]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; RJFSZMRLRWNKCP-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[3.1.1]heptan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.005; XSGGQEPWEZULLB-WDSKDSINSA-N; [M+H]+; (1R,5S)-3-azabicyclo[3.2.0]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; YOQFMSBXAJNJJA-UHFFFAOYSA-N; [M+H]+; 1-amino-3-cyclopropylpropan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.002; KMLPEYHLAKSCGX-UHFFFAOYSA-N; [M+H]+; 2-aminocyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.001; QQIZPINZVQELRS-UHFFFAOYSA-N; [M+H]+; 1-azaspiro[3.3]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; LSSWTAXATYJJOT-UHFFFAOYSA-N; [M+H]+; 3-azabicyclo[3.1.1]heptan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; OOMIMZFFLZQKIU-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-7-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.997; TWQMJAQGXUVGOA-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.1.1]hexan-1-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; IXXBUEAWNGTYSS-UHFFFAOYSA-N; [M+H]+; 2-azabicyclo[2.1.1]hexan-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.995; GGYVTHJIUNGKFZ-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; AFLIGFFKSOPBNA-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)cyclopentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; BKHTZJDZHRFTEW-UHFFFAOYSA-N; [M+H]+; 1,2,3,6-tetrahydropyridin-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.979; MNJYWTHQNUBTIC-RITPCOANSA-N; [M+H]+; (2S,3R)-2-ethenyloxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.978; JPXSWTRRFQUJTC-UHFFFAOYSA-N; [M+H]+; 3,6-dihydro-2H-pyran-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.974; SZEYBIHWBKIRJG-UHFFFAOYSA-N; [M+H]+; 4-oxaspiro[2.4]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; JXSAWOLLGHOTJJ-UHFFFAOYSA-N; [M+H]+; 2-azaspiro[3.3]heptan-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; DVOBWGYOTJOCAJ-UHFFFAOYSA-N; [M+H]+; 3,4-dihydro-2H-pyran-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.970; HZAPWKALBWQUQD-UHFFFAOYSA-N; [M+H]+; 2-amino-1-cyclobutylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; HEOZZUBPQNUUPG-HSUXUTPPSA-N; [M+H]+; (1R,6R,7R)-2-oxabicyclo[4.1.0]heptan-7-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; ILYYOUOYMCOHSN-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.966; QTSOGHFBXHIBFM-HCWXCVPCSA-N; [M+H]+; (1R,5S,6S)-2-oxabicyclo[3.2.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; ZFDMYXRXSBKBLF-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[3.1.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; GTYBCXLDMBKOHV-NTSWFWBYSA-N; [M+H]+; (1R,6S)-3-oxabicyclo[4.1.0]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.960; YFSGRMONVCFYTC-UHFFFAOYSA-N; [M+H]+; 2,4,5-trimethyl-2,5-dihydro-1,3-oxazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.957; JNABLKYNVDCEJC-UHFFFAOYSA-N; [M+H]+; 1-oxaspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.956; WHCQIGAGLHHFPZ-JKUQZMGJSA-N; [M+H]+; (1S,4S,6R)-2-oxabicyclo[2.2.1]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.954; GMXKRJFFSCDIAQ-UHFFFAOYSA-N; [M+H]+; 1-[1-(aminomethyl)cyclopropyl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; YGYOQZPGFXHQMW-XEAPYIEGSA-N; [M+H]+; [(1R,5S)-3-azabicyclo[3.1.0]hexan-6-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; YJOCNEVFWOGVQR-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.2.1]heptan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.950; PNBUAUKWRXPJFK-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.1.1]hexan-1-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; NVHRHGWRVNFFIB-UHFFFAOYSA-N; [M+H]+; 2-oxabicyclo[2.1.1]hexan-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; AHVAATWZOGWTOX-UHFFFAOYSA-N; [M+H]+; 1-methyl-2-oxabicyclo[2.1.1]hexan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.933; OTCYOBLTAQTFPW-UHFFFAOYSA-N; [M+H]+; 4-aminocyclohexan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.931; OUFBLTGDJDQVTA-UHFFFAOYSA-N; [M+H]+; 2-oxaspiro[3.3]heptan-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; SSZMVNBVJGCVFK-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)cyclopentan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.912; POOPWPIOIMBTOH-UHFFFAOYSA-N; [M+H]+; 8-oxa-3-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; AWZIRBSKQVRHQS-UHFFFAOYSA-N; [M+H]+; 3-oxabicyclo[3.1.0]hexan-6-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; QOQPLUHKCHMZSQ-UHFFFAOYSA-N; [M+H]+; 3,6-dihydro-2H-pyran-4-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.889; XBZJFFHSLIVHCZ-NGJCXOISSA-N; [M+H]+; (1S,2R,4R)-7-azabicyclo[2.2.1]heptan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; XPMMAKUHNMSONL-UHFFFAOYSA-N; [M+H]+; 6-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; DZOONCSMZVPSHJ-UHFFFAOYSA-N; [M+H]+; 7-oxabicyclo[2.2.1]heptan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.802; QWJRZIUNOYNJIQ-UHFFFAOYSA-N; [M+H]+; 2-ethyl-2-hydroxybutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.799; QRWZCJXEAOZAAW-UHFFFAOYSA-N; [M+H]+; N,N,2-trimethylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; QMXPTUUFGSTIKK-UHFFFAOYSA-N; [M+H]+; 5-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; BCNBMSZKALBQEF-UHFFFAOYSA-N; [M+H]+; 1,3-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.783; ZRBMHTFPJMSUDJ-UHFFFAOYSA-N; [M+H]+; 3-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.782; ZBCUGJNJBOSHIA-UHFFFAOYSA-N; [M+H]+; 4-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; PHGAOXNFCZKFTR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.778; NSRPFJGOCZUUHE-UHFFFAOYSA-N; [M+H]+; 5-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.777; IYZVTTRRGCJXGK-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.777; PTSGHGGLRADEFP-UHFFFAOYSA-N; [M+H]+; 4-methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.774; MNILDQSRDHCFJG-UHFFFAOYSA-N; [M+H]+; 3-oxa-8-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.774; IAXUBUNOIDLOLR-UHFFFAOYSA-N; [M+H]+; 3,4-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; HGVPKAGCVCGRDQ-UHFFFAOYSA-N; [M+H]+; 4,4-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.772; QPJCYJIZFCJYIR-UHFFFAOYSA-N; [M+H]+; 4-propylazetidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.766; HQQVXVKQOPZRBJ-UHFFFAOYSA-N; [M+H]+; 3,3a,4,5,6,6a-hexahydro-1H-furo[3,4-c]pyrrole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.762; KTWRIXHINMYODR-UHFFFAOYSA-N; [M+H]+; 3-methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.762; GMHPWGYTSXHHPI-UHFFFAOYSA-N; [M+H]+; azepan-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.761; FYCFJMPASVKULQ-UHFFFAOYSA-N; [M+H]+; 1-pyrrolidin-2-ylethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.760; ZHAIMJRKJKQNQI-UHFFFAOYSA-N; [M+H]+; 2-oxa-7-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.756; ZTXSXVWHVLDJQB-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylpyrrolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.753; SGNDFJVXTXKBGO-PHDIDXHHSA-N; [M+H]+; (1S,6R)-8-oxa-3-azabicyclo[4.2.0]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; QJIFFAMGOQBKPK-UHFFFAOYSA-N; [M+H]+; 6-oxa-3-azabicyclo[3.2.1]octane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.743; UUTGCNVYKLQLRV-UHFFFAOYSA-N; [M+H]+; 5,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.736; URLVRPKEOGBFHJ-UHFFFAOYSA-N; [M+H]+; 4,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.734; XKDPBYCPNJRCSM-UHFFFAOYSA-N; [M+H]+; 3,5-dimethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.721; SAOOLIIHRNLCBT-UHFFFAOYSA-N; [M+H]+; 2-hydroxy-3,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.697; HUUPVABNAQUEJW-UHFFFAOYSA-N; [M+H]+; 1-methylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.686; UWJKJTAFQCZBLA-UHFFFAOYSA-N; [M+H]+; 4-hydroxy-2,2-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.680; LNDYIZFLFMYMEO-UHFFFAOYSA-N; [M+H]+; 3-hydroxy-2,2-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; DOTBWZRLSYDMSC-LURJTMIESA-N; [M+H]+; (2S)-2-hydroxy-2-methylpentanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.677; VKIGAWAEXPTIOL-LURJTMIESA-N; [M+H]+; (2S)-2-hydroxyhexanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.664; UMECPVGLNIYFEO-UHFFFAOYSA-N; [M+H]+; 4-propan-2-ylazetidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -39.063; JBKVHLHDHHXQEQ; [M+H]+; Extrom 6m
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.884; PHGAOXNFCZKFTR; [M+H]+; 3-Methylpiperidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -94.443; ZRBMHTFPJMSUDJ; [M+H]+; 3-ethylpyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -105.214; XRLDSWLMHUQECH; [M+H]+; Cyclopentancarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -132.497; XPMMAKUHNMSONL; [M+H]+; zlchem 1132
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -134.557; VRVUKQWNRPNACD; [M+H]+; pentylisocyanate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.105; XHLCYFVJQKWNRH; [M+H]+; Piperidine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -138.514; VEZUQRBDRNJBJY; [M+H]+; Antioxidant D
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.368; QPJCYJIZFCJYIR; [M+H]+; beta-Caprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -157.656; GGYVTHJIUNGKFZ; [M+H]+; N-methylpiperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -157.712; FYCFJMPASVKULQ; [M+H]+; 2-Acetylpyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.348; ZFPGARUNNKGOBB; [M+H]+; N-Ethylpyrrolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.152; HGVPKAGCVCGRDQ; [M+H]+; 4,4-Dimethyl-2-pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.234; GXCJLVVUIVSLOQ; [M+H]+; 2-Propyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.547; FDCJCIRHYZNLDV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.110; DVOBWGYOTJOCAJ; [M+H]+; 2H-Pyran, 3,4-dihydro-2-aminomethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.544; YBZQRYWKYBZZNT; [M+H]+; ACMC-20dplt
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.494; YNTUHDRALXNDEQ; [M+H]+; o-Methylvalerolactim
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -180.305; HOSRHDUJWMTWRD; [M+H]+; Pentane, 2-isocyanato-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.240; SIKTVUHUQZNEPY; [M+H]+; 1-Methyl-3-piperidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.476; UFWIDNCIQKQRIJ; [M+H]+; Butyrylethylenimine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -186.503; UXKZFJDNFBNQHE; [M+H]+; ((1s,4r)-4-aminocyclopent-2-enyl)methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.644; HUUPVABNAQUEJW; [M+H]+; zlchem 508
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.229; RBCSSAWYWYRREH; [M+H]+; 3-propoxypropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.523; YGYOQZPGFXHQMW; [M+H]+; azabicyclohexanylmethanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.825; BCNBMSZKALBQEF; [M+H]+; Pyrrolidinone, dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.856; USXSCBCCYNVIPN; [M+H]+; (3-Bromo-phenyl)-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -207.861; WDFKEEALECCKTJ; [M+H]+; N-propyl-2-propenamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.415; FEWLNYSYJNLUOO; [M+H]+; Formylpiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.383; ZHAIMJRKJKQNQI; [M+H]+; 2-oxa-6-azaspiro[3.4]octane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.218; UWJKJTAFQCZBLA; [M+H]+; Butanenitrile, 4-hydroxy-2,2-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.479; BMSYXLRQGIFLFO; [M+H]+; 3-Isopropoxypropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.918; FILVIKOEJGORQS; [M+H]+; 1,5-Dimethyl-2-pyrrolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.108; DVQLGAFYVKJEDE; [M+H]+; NN-Dimethylcyclopropanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.403; KUQSQOIIMSDGFF; [M+H]+; Hexahydro-furo[2,3-c]pyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.381; VCUVETGKTILCLC; [M+H]+; Lopac-D-5766
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.045; UHSSZVLSEAEFTI; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.923; GORGQKRVQGXVEB; [M+H]+; N-Ethyl-N-vinylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.924; IVKKELNYLUICGF; [M+H]+; 1-hydroxy-2,2-dimethyl-3,4-dihydropyrrol-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.213; QZSYZIDYWNAACS; [M+H]+; 4-ethyl-2,3-dihydro-1,4-oxazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.431; ZCYVBYQBOWLNBU; [M+H]+; 1-(2-Methyl-1-oxopropyl)aziridine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.135; QWJRZIUNOYNJIQ; [M+H]+; 3-Pentanone cyanohydrin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.819; TWQMJAQGXUVGOA; [M+H]+; 2-Azabicyclo[2.1.1]hexane-1-methanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.766; FVEZUCIZWRDMSJ; [M+H]+; 2-Isopropyl-2-oxazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.088; WXYJAPNVTUNRQN; [M+H]+; 1-amino-2-methylpent-1-en-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.232; DZOONCSMZVPSHJ; [M+H]+; 7-oxabicyclo[2.2.1]heptan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.458; QNILTEGFHQSKFF; [M+H]+; Nipam
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.954; RHDNNKQDLVQQLJ; [M+H]+; 1-(propan-2-yl)aziridine-2-carbaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -254.989; QCKRFEBWZBKGTR; [M+H]+; 2-hydroxy-2,3-dimethylbutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.025; AOCHNXXMYIQWEH; [M+H]+; Oxazole, 4,5-dihydro-2,4,5-trimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.794; SAOOLIIHRNLCBT; [M+H]+; ACMC-20maot
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.111; LJJFNFYPZOHRHM; [M+H]+; Sestamibi
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.454; MJVIZWIQHKRBPI; [M+H]+; Aethoxen
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.148; YFSGRMONVCFYTC; [M+H]+; ACMC-20aoff
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.683; FNMKFVXIVPDFBL; [M+H]+; 4-Methylaminopent-3-en-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.116; QPWSKIGAQZAJKS; [M+H]+; 4-(dimethylamino)-3-buten-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.659; XEXRMKMMZOZZIF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.684; CEMLHCYKDRPMSS; [M+H]+; Methoxypivalonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -287.675; HZRZMHNRCSIQFT; [M+H]+; 2,4,4-trimethyl-5H-oxazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.517; QRWZCJXEAOZAAW; [M+H]+; N,N,2-Trimethylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -315.855; JGAMOQYFDMQPRJ; [M+H]+; 3-(Dimethylamino)methacrylaldehyde
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -350.233; GZTXSSQZAMMARW; [M+H]+; 3,4,4-trimethyl-5H-1,3-oxazol-3-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.704; JBKVHLHDHHXQEQ; [M+H]+; Extrom 6m
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -64.634; QQKQVOVFPXDPEM; [M+H]+; 3-Cyclopropylpropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -83.813; MOVYTRCXDKYPEP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -84.129; LWOAPRXHRHXWSO; [M+H]+; Oxopropylallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -84.311; XJNVWPWYFFZFCF; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -85.530; JJQXZWAHTLVGHM; [M+H]+; Cyclobutaneacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -88.447; GXHADJIRNTWYOG; [M+H]+; 6-Aminohex-1-yn-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -89.335; IVQAWSIUPSEIAC; [M+H]+; 3,4,5,6-Tetrahydro-2H-azepine 1-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -89.739; JBKVHLHDHHXQEQ; [M+H]+; Caprolactam
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.102; XRLDSWLMHUQECH; [M+H]+; Cyclopentanecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -90.524; XNZCIUOOZOLPOK; [M+H]+; 4-(Aminomethyl)pent-4-enal
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.466; QQKQVOVFPXDPEM; [M+H]+; 3-Cyclopropylpropanamide
COMMENT: CONFIDENCE Level 3: Tentative candidate, Epsilon-caprolactam, JBKVHLHDHHXQEQ-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (7), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0062769;
CH$NAME: Epsilon-caprolactam
CH$NAME: azepan-2-one
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H11NO
CH$EXACT_MASS: 113.084064
CH$SMILES: C1CCC(=O)NCC1
CH$IUPAC: InChI=1S/C6H11NO/c8-6-4-2-1-3-5-7-6/h1-5H2,(H,7,8)
CH$LINK: CHEBI CHEBI:28579
CH$LINK: HMDB HMDB0062769
CH$LINK: INCHIKEY JBKVHLHDHHXQEQ-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:7768
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.351
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 114.091299
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-6900000000-d7805c916b6b2d814b82
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0180724 12.1742 55.018780 0.9997 2.57 0.2848 44 f{C3H3O1}/4.20ppm,p-C3H9N1
  55.0545172 22.4943 55.055225 0.9808 3.14 0.6496 44 f{C4H7}/5.28ppm,p-C2H5N1O1
  67.0543685 21.0219 67.055110 0.9395 3.81 0.2809 44 f{C5H7}/2.12ppm,p-C1H5N1O1
  68.0496376 18.6824 68.050380 0.9552 2.55 0.5363 44 f{C4H6N1}/2.38ppm,p-C2H6O1
  69.0336270 25.1848 69.034370 0.9271 3.65 0.5893 44 f{C4H5O1}/1.97ppm,p-C2H7N1
  69.0700170 127.7152 69.070760 0.3330 7.42 0.7592 44 f{C5H9}/2.03ppm,p-C1H3N1O1
  70.0652167 11.8781 70.065960 1.1275 2.40 0.2004 43 f{C4H8N1}/1.30ppm,p-C2H4O1
  70.0733117 6.6762 70.074055 1.4984 1.75 0.1399 38 ?
  71.0492268 10.2909 71.049970 1.1119 2.37 0.2938 44 f{C4H7O1}/1.20ppm,p-C2H5N1
  71.0856168 10.6315 71.086360 0.9285 2.39 0.5183 43 f{C5H11}/1.27ppm,p-C1H1N1O1
  72.0808621 24.3650 72.081605 0.7908 16.79 -0.1015 44 f{C4H10N1}/1.20ppm,p-C2H2O1
  72.9372426 128.6886 72.937985 0.3428 32.17 0.7642 44 ?
  73.0469077 35.1697 73.047650 0.7529 11.55 0.5990 44 ?
  74.9375997 8.8746 74.938340 1.3745 2.83 0.4402 34 ?
  79.0542978 170.3974 79.055030 0.3289 10.73 0.8245 44 f{C6H7}/0.90ppm,p-H5N1O1
  80.0576305 10.9567 80.058360 0.9618 2.13 0.3187 44 ?
  84.0807645 5.7713 84.081480 1.4272 1.34 0.1293 33 f{C5H10N1}/-0.13ppm,p-C1H2O1
  86.0964684 16.1011 86.097175 0.9060 5.46 0.0755 44 f{C5H12N1}/0.49ppm,p-C1O1
  90.9476796 14.8557 90.948360 1.0446 3.81 0.7057 42 ?
  91.0573803 24.9944 91.058060 1.0323 8.35 0.5414 42 ?
  96.0807851 106.7098 96.081430 0.4267 7.54 0.7834 44 f{C6H10N1}/0.10ppm,p-H2O1
  97.0648428 38.3202 97.065480 0.7933 4.48 0.5914 44 f{C6H9O1}/0.53ppm,p-H3N1
  97.0840979 7.3785 97.084735 1.3184 1.77 0.2018 36 ?
  113.0232705 7.7701 113.023770 1.3360 2.42 -0.1141 31 ?
  113.0597008 21.9401 113.060200 1.1056 3.45 0.4358 36 ?
  113.9636680 9.9480 113.964160 1.2636 3.40 0.7152 39 ?
  114.0913790 999.0000 114.091870 0.2629 0.00 1.0000 44 f{C6H12N1O1}/0.34ppm,p
  115.0947273 71.9354 115.095210 0.5648 5.46 0.7908 44 ?
PK$NUM_PEAK: 28
PK$PEAK: m/z int. rel.int.
  55.018072 12.17 12
  55.054517 22.49 22
  67.054368 21.02 21
  68.049638 18.68 18
  69.033627 25.18 25
  69.070017 127.72 127
  70.065217 11.88 11
  70.073312 6.68 6
  71.049227 10.29 10
  71.085617 10.63 10
  72.080862 24.36 24
  72.937243 128.69 128
  73.046908 35.17 35
  74.937600 8.87 8
  79.054298 170.40 170
  80.057631 10.96 10
  84.080765 5.77 5
  86.096468 16.10 16
  90.947680 14.86 14
  91.057380 24.99 24
  96.080785 106.71 106
  97.064843 38.32 38
  97.084098 7.38 7
  113.023271 7.77 7
  113.059701 21.94 21
  113.963668 9.95 9
  114.091379 999.00 999
  115.094727 71.94 71
//
